DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20183012

Antimicrobial stewardship: need of the hour

Razi Ahmad, Sana Rehman

Abstract


Efforts to tackle the global threat of Antimicrobial Resistance (AMR) have recently taken shape in a number of potentially far-reaching collaborative initiatives. When microbes become resistant to medicines, the options for treating the diseases they cause are reduced. This resistance to antimicrobial medicines is happening in all parts of the world for a broad range of microorganisms with an increasing prevalence that threatens human and animal health. The direct consequences of infection with resistant microorganisms can be severe, including longer illnesses, increased mortality, prolonged hospital stay, loss of protection for patients undergoing operations and other medical procedures, and increased costs. Antimicrobial resistance affects all areas of health, involves many sectors and has an impact on the whole of society. To overcome the threat of antimicrobial resistance, a three-pillar approach has been advocated i.e. Optimize the use of existing antimicrobial agents, prevent the transmission of drug-resistant organisms through infection control and Improve environmental decontamination. Antimicrobial stewardship [AMSP] is one of the key strategies to overcome resistance. It is an inter-professional effort, across the continuum of care, involves timely and optimal selection, dose and duration of an antimicrobial for the best clinical outcome for the treatment or prevention of infection with minimal toxicity to the patient and minimal impact on resistance and other ecological adverse events.


Keywords


Antimicrobial stewardship programme, Antimicrobial resistance, Antimicrobial

Full Text:

PDF

References


Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases. 2007 Jan 15;44(2):159-77.

Centres for Disease Control and Prevention (CDC). Core 7. elements of Hospital Antibiotic Stewardship Programs. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2014. Available at: http://www.cdc.gov/getsmart/healthcare/pdfs/core-elements.html. Accessed on August 19, 2014.

Dyar OJ, Huttner B, Schouten J. What is antimicrobial stewardship? Clin Microbiol Infect. 2017 Nov;23(11):793-8.

Fleming, Alexander. The Penicillin Finder Assays its Future. The New York Times; June 25, 1945:21.

Reimann HA, D’Ambola J. 30-50% of antimicrobial use is either unnecessary or inappropriate. JAMA. 1968;205(7):537.

Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S146-5. [PubMed]

Hoa NQ, Trung NV, Larsson M, Eriksson B, Phuc HD, Chuc NT, et al. Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study. BMC Infect Dis. 2010;10:85. [PMC free article] [PubMed]

Mathai E, Chandy S, Thomas K, Antoniswamy B, Joseph I, Mathai M, et al. Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in Southern India. Trop Med Int Health. 2008;13:41-5. [PubMed]

Jain D, Sinha S, Prasad KN, Pandey CM. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg. 2005;99:207-14. [PubMed]

Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilvert D, Rice LB, et al. Bad buds, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Disease. 2009;48:1-12.

Biomerieux. Practical guide to Antimicrobial Stewardship in hospitals. Biomerieux, France; 2013:4.

Centers for Disease Control and Prevention. Core elements of antibiotic stewardship programs. Available at: http://www.cdc.gov/getsmart/healthcare/implementat ion/core-elements.html.

Lenhard JR. Nation RL and Tsuji BT. Synergistic combinations of Polymyxins. Int J Antimicrob Agents. 2016;48(6):607-13.

Goossens H, Ferech M, Vander Stichele R, Elseviers M ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87. [PubMed]

Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby LC. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother. 2013;68:229-36. [PubMed]

Kumari IS, Chandy SJ, Jeyaseelan L, Kumar R, Suresh S. Antimicrobial prescription patterns for common acute infections in some rural and urban health facilities of India. Indian J Med Res. 2008;128:165-71. [PubMed]

Dellit TH, Owens RC, McGowan JE, Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77. [PubMed]

Centres for Disease Control and Prevention (CDC). Core 7. elements of Hospital Antibiotic Stewardship Programs. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2014. Available at: http://www.cdc.gov/getsmart/healthcare/pdfs/core-elements.html, accessed on August 19, 2014.

Chandy SJ, Michael JS, Veeraraghavan B, Abraham OC, Bachhav SS, Kshirsagar NA. ICMR programme on antibiotic stewardship, prevention of infection & control (ASPIC). Ind J Med Resea. 2014 Feb;139(2):226.

World Heath Organization (WHO). Antimicrobial resistance: global report on surveillance. Geneva: WHO; 2014.

Howard SJ, Catchpole M, Watson J, Davies SC. Antibiotic 2. resistance: global response needed. Lancet Infect Dis. 2013;13:1001-3.

Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance- the need for global solutions. The Lancet infectious diseases. 2013 Dec 1;13(12):1057-98.

Brink AJ, Messina AP, Feldman C, Richards GA, Becker PJ, Goff DA, et al. Antimicrobial stewardship across 47 South African hospitals: an implementation study. The Lancet Infectious Diseases. 2016 Sep 1;16(9):1017-25.

Lesho EP, Waterman PE, Chukwuma U, McAuliffe K, Neumann C, Julius MD, et al. The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance. Clinical Infectious Diseases. 2014 May 1;59(3):390-7.

Willemsen I, Oome S, Verhulst C, Pettersson A, Verduin K, Kluytmans J. Trends in extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae and ESBL genes in a Dutch teaching hospital, measured in 5 yearly point prevalence surveys (2010-2014). PLoS One. 2015;358:e0141765.

Lesho EP, Waterman PE, Chukwuma U, McAuliffe K, Neumann C, Julius MD, et al. The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance. Clinical Infectious Diseases. 2014 May 1;59(3):390-7.

Hawkey PM, Warren RE, Livermore DM, McNulty CA, Enoch DA, Otter JA, et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/healthcare Infection Society/british Infection Association Joint Working Party. J Antimicrob Chemother. 2018 Mar 1;73(3):iii2-78.

Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med. 2016;358:e1001974.

Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742-50.

Rattan A, Bhujwala RA, Kumar RS. Organization of infection control program. J Acad Hosp Adm. 1992;4:21-5. [PubMed].

Sureshkumar D, Gopalakrishnan R, Ramasubramanian V. Survey of infection control programs in India. Poster presentation in ID week; October 2013:2-6. San Francisco. Available at: https://idsa.confex.com/idsa/2013/webprogram/Paper42 762.html.

Walia K, Ohri VC, Mathai D. Antimicrobial stewardship programme (AMSP) practices in India. Ind J Med Resear. 2015 Aug;142(2):130.

Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113-23.

Giblin TB, Sinkowitz-Cochran RL, Harris PL, Jacobs S, Liberatore K, Palfreyman MA, et al. Clinicians' perceptions of the problem of antimicrobial resistance in health care facilities. Archives of internal medicine. 2004 Aug 9;164(15):1662-8.

Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692-701.

Hranjec T, Rosenberger LH, Swenson W, Metzqer R, Flohr TR, Politano AD, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infections: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis. 2012;12:774-80.

Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related blood stream infections in the ICU. N Engl J Med. 2006;355:2725-32.

Weber DJ, Anderson D, Rutala WA. The role of the surface 19. environment in healthcare-associated infections. Curr Opin Infect Dis. 2013;26:338-44.

World Health Organization (WHO). Antimicrobial resistance- Global report on surveillance. WHO Press; 2014. Available at: http://apps.who.int/iris/bitstream /10665/112642/1/9789 241564748_eng.pdf?ua=1.

Allegranzi B, Luzzati R, Luzzani A, Girardini F, Antozzi L, Raiteri R, et al. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. Journal of Hospital Infection. 2002 Oct 1;52(2):136-40.